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Abstract
Background: Mice with conditional, intestine-specific deletion of microsomal triglyceride transfer protein (Mttp-IKO) exhibit
a complete block in chylomicron assembly together with lipid malabsorption. Young (8–10 week) Mttp-IKO mice have
improved survival when subjected to a murine model of Pseudomonas aeruginosa-induced sepsis. However, 80% of deaths
in sepsis occur in patients over age 65. The purpose of this study was to determine whether age impacts outcome in Mttp-
IKO mice subjected to sepsis.
Methods: Aged (20–24 months)Mttp-IKOmice and WT mice underwent intratracheal injection with P. aeruginosa. Mice were
either sacrificed 24 hours post-operatively for mechanistic studies or followed seven days for survival.
Results: In contrast to young septic Mttp-IKO mice, aged septic Mttp-IKO mice had a significantly higher mortality than aged
septic WT mice (80% vs. 39%, p = 0.005). Aged septic Mttp-IKO mice exhibited increased gut epithelial apoptosis, increased
jejunal Bax/Bcl-2 and Bax/Bcl-XL ratios yet simultaneously demonstrated increased crypt proliferation and villus length. Aged
septic Mttp-IKO mice also manifested increased pulmonary myeloperoxidase levels, suggesting increased neutrophil
infiltration, as well as decreased systemic TNFa compared to aged septic WT mice.
Conclusions: Blocking intestinal chylomicron secretion alters mortality following sepsis in an age-dependent manner.
Increases in gut apoptosis and pulmonary neutrophil infiltration, and decreased systemic TNFa represent potential
mechanisms for why intestine-specific Mttp deletion is beneficial in young septic mice but harmful in aged mice as each of
these parameters are altered differently in young and aged septic WT and Mttp-IKO mice.
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Introduction
Sepsis affects over 800,000 patients annually in the United
States, and between 230,000 and 370,000 patients die of the
disease annually [1]. Sepsis is a disease of the aged. Even though
elderly patients account for slightly greater than 10% of the
population in the United States, more than 60% of cases of sepsis
and approximately 80% of deaths occur in patients over 65 years
of age [2,3]. Both animal and human studies demonstrate that age
greatly impacts the host response following sepsis and not only is
mortality higher with aging, but also multiple therapies that are
effective in young mice are ineffective in aged mice [4–12].
Despite this, the vast majority of rodent models of sepsis use 6–16
week old animals, which corresponds to a 10–17 year old human
[13]. It has been suggested that the use of young animals to model
a disease of the aged – which have altered inflammation,
coagulation, apoptosis, and proteomics – is one of many reasons
why preclinical models of sepsis have failed to translate into
positive clinical trials [14,15].
The gut has long been hypothesized to be ‘‘the motor’’ of the
systemic inflammatory response syndrome [16–19]. Critical illness
worsens gut integrity in a number of ways, including increasing
intestinal epithelial apoptosis and permeability while simulta-
neously decreasing both proliferation and mucous production [20–
44]. The microbiome of the gut – which ordinarily exists in a
symbiotic relationship with the host – can also respond to
environmental cues in sepsis to induce virulence factors, which
can, in turn, worsen critical illness [45–48]. Additionally, toxic gut-
derived lymph induces distant organ injury in critical illness as
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numerous lines of evidence support the ‘‘gut lymph’’ hypothesis in
which the intestine releases toxic mediators that are transported
through the mesenteric lymph nodes and cause damage remote
from the intestine [49–57].
The role of intestinal chylomicron assembly and secretion in
transporting toxic gut-derived lipid factors is poorly understood.
Microsomal triglyceride transfer protein (Mttp) resides within the
lumen of the endoplasmic reticulum and plays a requisite role in
the assembly of triglyceride-rich lipoprotein particles, both within
enterocytes of the small intestine and also in hepatocytes of the
liver [58]. We previously studied the impact of sepsis in young (8–
10 week old) mice with defective chylomicron assembly induced by
conditional intestine-specific deletion of Mttp (Mttp-IKO mice)
[59]. Compared to young septic wild type (WT) mice, young septic
Mttp-IKO mice have increased survival. This is associated with
improvements in gut integrity, manifested by decreased gut
apoptosis, increased crypt proliferation and longer villus length.
Young septic Mttp-IKO mice also have marked decreases in
systemic IL-6 and G-CSF. Despite pneumonia being initiated in
the lungs, no significant pulmonary differences exist between
young septic Mttp-IKO and WT mice, with similar levels of MPO
activity, bacterial clearance and broncoalveolar lavage (BAL)
cytokines. The aim of this study was to determine if aging alters




Aged (defined as 20–24 months old) Mttpflox/flox villin-Cre-
ERT2 (Mttp-IKO) mice on a background of ,75% C57BL/6 and
,25% 129/SvJ were utilized for all experiments. Conditional,
intestine-specific deletion of Mttp was induced via Cre recombi-
nase expression in villus epithelial cells in which animals received
five daily injections of tamoxifen given intraperitoneally (1 mg,
Sigma, St. Louis, MO) [59,60]. Experiments were performed three
weeks after tamoxifen injections. Age matched littermate animals
that did not receive tamoxifen (i.e. functionally WT) were used as
controls. All experiments were performed in accordance with the
National Institutes of Health Guidelines for the Use of Laboratory
Animals and were approved by the Institutional Animal Care and
Use Committee at Emory University School of Medicine (Protocol
DAR-2000539-121812). All surgery (described below) was per-
formed under isoflurane anesthesia and all efforts were made to
minimize animal suffering by treating all animals with buprenex
post-operatively. For non-survival studies, animals were sacrificed
24 hours following intratracheal injection of P. aeruginosa (detailed
below) using asphyxiation by CO2 or via exsanguination under
deep isoflurane anesthesia. A different subset of animals was
followed for 7 days after intratracheal injection of P. aeruginosa for
survival studies. Animals were checked twice daily. Moribund
animals were sacrificed using humane endpoints. The following
criteria were used to identify moribund animals: a) major organ
failure or medical conditions unresponsive to treatment such as
severe respiratory distress, icterus, uremia, intractable diarrhea, or
self-mutilation, b) surgical complications unresponsive to immedi-
ate intervention (bleeding, infection, wound dehiscence) or c)
clinical or behavioral signs unresponsive to appropriate interven-
tion persisting for 24 hours including significant inactivity, labored
breathing, sunken eyes, hunched posture, piloerection/matted fur,
one or more unresolving skin ulcers, and abnormal vocalization
when handled. Note that it is important that many classical
humane endpoints for animal studies are not sufficient for studies
in sepsis, as many animals meeting general guidelines criteria for
euthanasia survive despite sepsis. Specific guidelines for humane
endpoints in sepsis research [61,62] were followed. Non-moribund
animals that died during the course of the survival curve died as a
direct result of their septic insult. Animals that survived 7 days
after intratracheal injection of P. aeruginosa were sacrificed at the
conclusion of this experiment using asphyxiation by CO2.
Sepsis model
Under isoflurane anesthesia, all animals were subjected to
intratracheal injections of P. aeruginosa (ATCC 27853) via midline
cervical incision [63,64]. A total of 40 ml of bacteria diluted in
normal saline (2–46107 CFU) was injected via a 29 gauge syringe.
To enhance bacterial delivery, mice were held vertically for 10
seconds. All mice received a subcutaneous injection of 1 ml saline
post-operatively to compensate for insensible fluid losses. Animals
were either euthanized 24 hours post-operatively or followed 7
days for survival.
Intestinal morphology
Villus length was measured as the distance in mm from the crypt
neck to the villus tip. Crypt depth was measured as the distance in
mm from the crypt base to crypt neck. Each was measured in 12–
16 well-oriented jejunal villi and crypts using Nikon Elements
imaging software- EIS-Elements BR 3.10 (Nikon Instruments,
Melville, NY).
Intracellular lipid droplets were evaluated using osmium
tetoxide staining in intestinal tissue fixed in 10% neutral buffered
formalin. Sections were then transferred into 1% osmium
tetroxide, rinsed in distilled water, incubated in 0.5% periodic
acid, washed and then processed for paraffin embedding, followed
by counterstaining with hematoxylin and eosin (H&E).
Intestinal apoptosis
Apoptotic cells were quantified in the jejunum using two
independent but complementary techniques: active caspase-3
staining and morphologic analysis of H&E-stained sections [27].
For caspase-3 staining, sections were deparaffinized, rehydrated,
and incubated in 3% hydrogen peroxide for 10 minutes. Sections
were then placed in Antigen Decloaker (Biocare Medical,
Concord, CA) and heated in a pressure cooker for 45 minutes.
After sections were blocked with 20% normal goat serum (Vector
Laboratories, Burlingame, CA), they were incubated overnight
with rabbit polyclonal anti-active caspase-3 (1:100; Cell Signaling,
Beverly, MA) at 4uC. The following day, sections were incubated
Figure 1. Effect of impaired intestinal lipid transport on
mortality following P. aeruginosa pneumonia. Mice with intes-
tine-specific deletion of microsomal triglyceride transfer protein had
markedly increased mortality compared to WT mice when followed 7
days after induction of sepsis (n = 18–20/group, p = 0.005).
doi:10.1371/journal.pone.0101828.g001
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with goat anti-rabbit biotinylated secondary antibody (1:200;
Accurate Chemical and Scientific, Westbury, NJ) for 1 hour
followed by horseradish peroxidase (HRP)- labeled streptavidin
(Accurate Chemical and Scientific) for 1 hour. Sections were then
developed with diaminobenzidine and counterstained with hema-
toxylin.
Apoptotic cells were identified on H&E-stained sections via
characteristic morphological changes including cell shrinkage with
condensed and fragmented nuclei and then quantified in 100 well-
oriented contiguous crypt-villus units.
Intestinal proliferation
Mice were intraperitoneally injected with 5-Bromo-29deoxyur-
idine (BrdU, 5 mg/ml diluted in normal saline; Sigma) 90 minutes
prior to sacrifice to label cells in S-phase. Sections were
deparaffinized, rehydrated, incubated in 1% hydrogen peroxide
for 15 minutes, immersed in Antigen Decloaker (Biocare Medical)
and heated in a pressure cooker for 45 minutes. Sections were then
blocked with Protein Block (Dako, Carpinteria, CA) for 10
minutes, and incubated with rat monoclonal anti-BrdU overnight
at 4uC (1:500; Accurate Chemical & Scientific). The following day,
sections were incubated with goat anti-rat biotinylated secondary
antibody (1:500; Accurate Chemical and Scientific) for 1 hour,
followed by HRP labeled Streptavidin (Accurate Chemical and
Scientific) for 1 hour and then developed with diaminobenzidine
and counterstained with hematoxylin. BrdU-stained cells were
quantified in 100 well-oriented contiguous crypts.
Gene expression of apoptosis mediators
Total RNA was isolated from frozen jejunal tissue using the
RNeasy Mini Kit (QIAGEN, Santa Clarita, CA) according to
manufacturer protocol [59]. RNA integrity was verified by
electrophoresis and cDNA was synthesized from 0.5 mg of total
RNA. Bax, Bcl-2, and Bcl-xL mRNA levels were detected using
pre-developed TaqMan primers and probes (Applied Biosystems,
Foster City, CA) and run on the ABI StepOnePlus Real-Time
PCR system (Applied Biosystems). Samples were run in duplicate
and normalized to expression of the endogenous control,
glyceraldehyde-3-phosphate. Relative quantification of PCR
products were based upon value differences between the target
gene and glyceraldehyde-3-phosphate using the comparative CT
method.
Bacterial cultures
Bronchoalveolar lavage (BAL) fluid was obtained by cannulat-
ing the trachea and lavaging the lungs with 1 ml of sterile saline.
BAL samples were serially diluted in sterile saline and plated on
sheep’s blood agar plates. Plates were incubated overnight at 37uC
in 5% CO2 and colony counts were determined 24 hours later.
From plates containing fewer than 300 colonies.
Myeloperoxidase (MPO) activity
BAL fluid was centrifuged at 5,000 rpm for 5 minutes.
Following addition of substrate buffer containing O-dianisidine
and 0.0005% hydrogen peroxide, MPO activity was measured at
460 nm wavelengths over 6 minutes (Bio-Tek Instruments-
Synergy HT, Winooski, VT). MPO activity was calculated as
optical density/minute (U) per ml of BAL fluid.
Systemic and BAL cytokines
Blood was collected at time of sacrifice, centrifuged at
5,000 rpm for 5 minutes in serum separator tubes and stored at
Figure 2. Effect of impaired intestinal lipid transport on intestinal and liver lipids. Villi of aged septic WT (A) and Mttp-IKO (B) mice stained
with osmium tetroxide to detect intracellular lipid droplets. A massive upregulation is noted in these representative histomicrographs in Mttp-IKO
mice, (magnification 40x). Triglyceride concentrations were increased in the jejunal mucosa (C, n = 5/group, p = 0.008) but not in the liver (D, n = 5/
group, p = 0.056). Cholesterol levels were similar in both jejunal mucosa (E, n = 5/group, p.0.05) and liver (F, n = 5/group, p.0.05).
doi:10.1371/journal.pone.0101828.g002
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280uC until use. Both serum and BAL levels of IL-1b, IL-6, IL-
10, IL-13, MCP-1, and TNFa were measured by using a multiplex
cytokine assay (Bio-Rad) according to manufacturer’s instructions
[29]. All samples were run in duplicate.
Serum and tissue lipids
Blood was collected on the same animals immediately prior to
induction of pneumonia and 24 hours later. Serum trigylcerides
(TG) and cholesterol levels were determined using commercially
available kits (Wako Chemicals, Richmond, VA). Lipid quantita-
tion in the proximal jejunum was performed as previously
described [59]. Cholesterol and triglyceride distribution within
high density lipoproteins (HDL) and low density lipoproteins
(LDL) were quantified following fractionation using fast protein
liquid chromatography using tandem Superose 6 columns [65].
Serum bile acid levels were determined using an enzymatic assay
kit (Cat No. BQ-092A-EALD, BioQuatnt, San Diego, CA)accord-
ing to manufacturer’s instructions.
Liver and splenic pathology
H&E-stained section of liver and spleen were evaluated by a
pathologist blinded to sample identity (ABF).
Statistical analysis
Continuous data sets were tested for Gaussian distribution using
the D’Agostino-Pearson omnibus normality test. Comparisons
were performed using the Student’s t-test if data were found to
have a Gaussian distribution. Alternatively, if data did not have a
Gaussian distribution, comparisons were performed using the
Mann Whitney test. Data are presented as mean 6 SEM. Survival
curves were analyzed using the Log-Rank test. All data were
analyzed using the statistical software program Prism 4.0
(GraphPad, San Diego, CA), and a p value of ,0.05 was
considered to be statistically significant.
Results
Mortality is worsened in aged septic mice with impaired
lipid transport
To determine the functional significance of impaired lipid
transport, aged WT and Mttp-IKO mice were subjected to P.
aeruginosa pneumonia and followed 7 days for survival (Figure 1).
Septic WT mice had a 39% seven-day mortality, while septicMttp-
IKO mice had an 80% mortality.
Intestinal triglyceride mobilization is impaired in aged
septic Mttp-IKO mice
Defects in chylomicron assembly were associated with large
intracellular lipid droplets in aged septic Mttp-IKO mice (Fig. 2A,
B). Mucosal triglyceride content was increased as expected in aged
septic Mttp-IKO mice along with the expected decrease in hepatic
triglyceride content as previously observed in young Mttp-IKO
mice [60,65] (Fig. 2C, D). By contrast, mucosal and liver
cholesterol content was similar between aged septic Mttp-IKO
and WT mice (Fig. 2E, F).
Figure 3. Effect of impaired intestinal lipid transport on intestinal epithelial apoptosis. Intestinal epithelial apoptosis was increased in
Mttp-IKO mice by H&E staining (A, n = 11–16/group, p = .002) with a similar trend seen with active caspase 3 staining (B, n = 11–12/group, p = 0.07).
The ratio of pro-apoptotic Bax to anti-apoptotic Bcl-2 (C, n = 11–16/group, p = 0.02) and Bcl-xL (D, n = 8–11/group, p = 0.004) were both increased in
Mttp-IKO mice, consistent with elevated apoptosis.
doi:10.1371/journal.pone.0101828.g003
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Increased Intestinal epithelial apoptosis in aged septic
mice with impaired intestinal lipid transport
Intestinal epithelial apoptosis was significantly increased in aged
septic Mttp-IKO mice when assayed by H&E or active caspase 3
staining (Fig. 3A, B). The ratio of jejunal Bax/Bcl-2 (Fig. 3C) and
Bax/Bcl-xL (Fig. 3D) was also increased in aged septic Mttp-IKO
mice compared to aged septic WT mice, consistent with elevated
gut apoptosis. These findings are at variance with our prior
observations in young septic Mttp-IKO mice [59] and suggest that
the intestinal apoptotic response to systemic infection is age-
dependent.
Intestinal length and crypt proliferation are higher in
aged septic mice with impaired lipid transport
Villus length was significantly increased in aged Mttp-IKO mice
subjected to pneumonia compared to aged WT mice subjected to
the same insult (Fig. 4A, B). Crypt depth was also significantly
increased in aged septic Mttp-IKO mice (Fig. 4C). This was
associated with a significant increase in the number of proliferating
S phase crypt cells in aged septic Mttp-IKO mice as measured by
BrdU staining (Fig. 4D). These findings recapitulate those in
young, septic Mttp-IKO mice [59], suggesting that elements of the
response to systemic infection following attenuated chylomicron
formation are retained with age.
Pulmonary MPO levels are increased in aged septic mice
with impaired intestinal lipid transport
Since the infection in pneumonia is initiated in the lungs,
pulmonary injury was assayed next. MPO activity was significantly
elevated in BAL fluid of aged septic Mttp-IKO mice (Fig, 5A).
Despite this, bacteria were undetectable in the majority of both
septic WT and Mttp-IKO mice, and bacterial burden was low even
in animals from which P. aeruginosa could be recovered (Fig. 5B).
Pulmonary cytokines were generally similar between groups
except for a decrease in TNFa in aged septic Mttp-IKO mice
(Fig, 5C–H).
Systemic pro-inflammatory cytokines are decreased in
aged septic mice with impaired intestinal lipid transport
IL-6, MCP-1 and TNFa levels were all significantly decreased
24 hours after pneumonia in aged septic Mttp-IKO mice
(Figure 6A–C). In contrast, there were no significant differences
in the serum levels of IL-1b, IL-10 and IL-13 by genotype
(Figure 6D–F).
Figure 4. Effect of impaired intestinal lipid transport on villus and crypt length and proliferation. Villus length was longer in in Mttp-IKO
mice whether assayed qualitatively (A shows representative micrographs, magnification 10X) or quantitatively (B, n = 11–16/group, p,0.0001). Crypt
depth was also increased in Mttp-IKO mice (C, n = 11–16/group, p,0.0001). The number of s phase cells (D, n = 11–12/group, p = 0.002) was also
significantly higher in Mttp-IKO mice.
doi:10.1371/journal.pone.0101828.g004
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Liver and splenic blastoid cells are increased in aged
septic mice with impaired intestinal lipid transport
The number of liver blastoid cells was increased in aged septic
Mttp-IKO mice (Fig. 7A), although there were no significant
differences in the frequency of liver hematolymphoid cells or
enlarged, regenerative hepatocytes (Fig. 7B). Similarly, the number
of splenic blastoid cells was also increased in aged septic Mttp-IKO
mice (Fig. 7D). A marked increase in splenic megakaryocytes was
also identified (Fig. 7E) although no difference was detected in
splenic tingible body macrophages (Fig. 7F).
Impact of sepsis, impaired intestinal lipid transport and
combination on TG and cholesterol levels
TG and cholesterol concentrations in serum were both
decreased by sepsis in WT mice (Fig. 8A, B). Impaired intestinal
lipid transport was verified in aged Mttp-IKO mice with reduced
serum TG and cholesterol concentrations. However, while TG
levels were similar pre- and post- sepsis in Mttp-IKO mice, serum
cholesterol levels rose modestly after the onset of sepsis inMttp-IKO
mice as noted previously in young septic Mttp-IKO mice [59].
Lipoprotein distribution as inferred from FPLC fractionation
demonstrated that control septic mice have reduced lipid content
in large triglyceride rich lipoproteins (VLDL, fraction 10), while
septic Mttp-IKO mice showed a rise in HDL cholesterol, as
previously noted in young septic Mttp-IKO mice [59] (Fig. 8C–D).
These findings again verify that important elements of the lipid
homeostatic responses noted inMttp-IKO mice are retained in aged
mice. Serum bile acids were also examined since previous reports
have demonstrated elevated levels in association with liver
dysfunction in humans [66]. Bile acid levels were similar between
aged septic WT and aged septic Mttp-IKO mice (Fig. 8E).
Discussion
The central finding of this study is that mortality is markedly
increased in aged septic Mttp-IKO mice following P. aeruginosa-
induced sepsis. This observation directly contradicts findings in
genetically identical young mice where blocking intestinal chylo-
micron assembly results in a survival benefit. Since the major
difference in experimental design between this study and our prior
study on young septic Mttp-IKO mice [59] is mouse age, it is
reasonable to conclude that age plays an important role in the
divergent survival in young vs. aged Mttp-IKO mice subjected to
sepsis. This is consistent with multiple previous studies that have
demonstrated that age greatly impacts the host response in sepsis,
Figure 5. Effect of impaired intestinal lipid transport on BAL MPO, cultures and cytokines. MPO levels were elevated in BAL fluid of Mttp-
IKO mice (A, n = 8/group, p = 0.001). Bacterial levels were low in both WT and Mttp-IKO mice, although the latter had less bacteria present in BAL fluid
(B, n = 9–11/group, p = 0.005). TNFa was lower in BAL fluid in Mttp-IKOmice (C, n = 7–8/group, p = 0.02) but no statistically significant differences were
noted in IL-6, MCP-1, IL-1b, IL-10 and IL-13 (D–H, n = 8–11/group, p.0.05 for each).
doi:10.1371/journal.pone.0101828.g005
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and interventions that are beneficial in young septic hosts fail to
improve or even worsen mortality in aged hosts [4–12].
When trying to understand the differential mortality between
young and aged septic Mttp-IKO mice, it is helpful to compare
some of the key physiologic and cellular parameters that we
observed. Parameters that are similarly changed between young
and aged Mttp-IKO mice compared to WT animals – such as villus
length, crypt proliferation, pulmonary and systemic cytokines – are
unlikely to play a causative role in the differential mortality
observed. In contrast, parameters in which results move in the
opposite direction (i.e. increased vs. decreased) or change in only
one group (i.e. increased vs. no difference) between young and
aged Mttp-IKO mice animals compared to WT animals could
potentially play a role in mediating the differential mortality
observed. It is notable, then, that of the multiple parameters
examined in this study, only gut apoptosis, pulmonary neutrophil
infiltration, systemic TNFA, and mucosal triglyceride concentra-
tion were different in young and aged septic Mttp-IKO mice when
compared to WT mice.
Gut epithelial apoptosis is increased in both mouse models and
human autopsy studies of sepsis [20,21,67]. This appears to be
physiologically significant since overexpression of Bcl-2 is associ-
ated with increased survival from sepsis from either P. aeruginosa or
cecal ligation and puncture (CLP) [20,21]. Numerous co-
morbidities including cancer and chronic alcohol abuse are
associated with increased sepsis-induced gut epithelial apoptosis.
Notably aging is also associated with increased gut apoptosis
[29,33,34]. Gut apoptosis is increased in aged Mttp-IKO mice in
this study, associated with increased ratios of both jejunal Bax/Bcl-
2 and Bax/Bcl-xL. Sepsis in isolation from either methicillin
resistant Staphylococcus aureus pneumonia or peritonitis increase both
pro (Bax) and anti (Bcl-xL) apoptotic mediators in the mitochon-
drial pathway [28,30], and the ratio of these plays a critical role in
determining whether a cell lives or dies. The finding that gut
apoptosis is increased in aged septic Mttp-IKO mice directly
contrasts with young septic Mttp-IKO mice, where gut apoptosis
was reduced. However, the mechanisms through which blocking
intestinal chylomicron alter gut apoptosis are unclear. Further, the
association between gut apoptosis and mortality does not
distinguish whether gut apoptosis is a mediator of mortality in
these studies or simply a marker of illness.
An association also exists between pulmonary neutrophil
infiltration and mortality in Mttp-IKO mice, with increased MPO
activity and mortality in aged septic mice while MPO activity was
unchanged in young septic Mttp-IKO mice compared to aged
matched septic WT mice [59]. Pulmonary neutrophil infiltration is
commonly seen in the acute respiratory distress syndrome [68–70].
While neutrophils play a beneficial role against pulmonary
pathogens, they also release toxic factors such as reactive oxygen
species and proteinases that contribute to progression of lung
disease. We do acknowledge that is counterintuitive that mice with
lower levels of pulmonary bacteria have a higher mortality.
However, most mice (both WT and knockout) had no bacteria
recovered from the lung 24 hours after the onset of pneumonia
and the average bacterial burden was only 100 cfu/ml in WT
mice. In the absence of detectable infection in most mice, it is
unlikely that the small difference in pulmonary bacterial burden
played a major role in mediating higher mortality in aged septic
Mttp-IKO mice. However, excessive pulmonary inflammation,
independent of infection, can lead to self-sustaining damage to
lung tissue and then secondarily lead to worsening systemic illness.
As such, increased pulmonary neutrophil infiltration represents a
Figure 6. Effect of impaired intestinal lipid transport on systemic cytokines. Serum TNFa (A, n = 9–12/group, p = 0.0001), IL-6 (B, n = 10–14/
group, p = 0.008), MCP-1 (C, n = 10–12/group, p = 0.03) were all lower in Mttp-IKO mice but no statistically significant differences were noted in IL-1b,
IL-10 and IL-13 (D–F, n = 10–16/group, p.0.05 for each).
doi:10.1371/journal.pone.0101828.g006
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plausible potential mechanism underlying mortality in aged septic
Mttp-IKO mice. Of note, in hemorrhagic shock, toxic mediators
are released from the intestine and transported through the
mesenteric lymph to the pulmonary circulation. Studies in rats
have demonstrated that mesenteric lymph duct ligation prevents
lung injury and improves survival in multiple animal models of
critical illness [19,50,52,71,72]. The lungs do not appear to be a
major contributor towards improved survival in young septic Mttp-
IKO mice, mice since decrease of lipid transport into mesenteric
lymph did not prevent lung injury. Accordingly, further work will
be required to resolve the mechanisms through which blocking
intestinal chylomicron alters pulmonary inflammation in an age-
dependent manner after sepsis.
One surprising finding was that Mttp-IKO mice generally had
lower levels of systemic cytokines. Typically, this would be thought
of as being associated with better outcomes rather than higher
mortality. However, it should be noted that a similar pattern of
lower systemic cytokines was seen in both aged and young Mttp-
IKO mice compared to age-matched WT mice. This suggests that
cytokine levels alone cannot be responsible for the differential
mortality seen between aged and young mice. It is unclear,
however, whether systemic cytokines played no role in survival or
if a beneficial role was superseded by a different detrimental
mechanism in aged mice. In this regard, it should be mentioned
that bacteremia was not different between aged Mttp-IKO and WT
mice (data not shown).
Patients in the ICU frequently have decreased serum lipids [73].
The functional significance of this observation is not clear. In
preclinical models, lipoprotein infusion improves mortality in
endotoxemia [74], a model of critical illness with some similarities
but also some key differences from sepsis. Alternatively, hyperli-
poproteinemic LDL receptor-deficient mice have increased
mortality following CLP [75]. It is noteworthy that the adaptive
homeostatic responses to sepsis noted in young Mttp-IKO mice
(increased HDL cholesterol content) appear to be recapitulated in
aged mice, but again it is unlikely that this is a determinant of the
paradoxical increase noted in mortality.
Another, albeit less likely, factor that could potentially play a
role in the differential mortality between young and aged mice is
severity of insult. Given that aged mice are more susceptible to
sepsis, it is necessary to lessen insult severity in aged animals in
order to match mortality between young and aged animals, since
aged animals have 100% mortality to sepsis models that cause
moderate lethality in younger mice [4]. Both age and severity of
insult independently mediate survival and alter the host response
following CLP, so it is possible that a differential bacterial burden
(rather than age) played a critical role in mediating mortality in
this study. Additionally, as alluded to above, while we attempted to
match mortality between young and aged mice, baseline mortality
from P. aeruginosa was 29% in our previous study of young mice
whereas baseline mortality from the same organism was 39% in
this study. While this difference is relatively small, the risk of death
prior to intervention has been shown to play a large role in how (or
if) a host responds to a putative sepsis therapeutic [76,77], and it is
possible that this seemingly small difference in baseline mortality
Figure 7. Effect of impaired intestinal lipid transport on liver and spleen cells. In the liver, there was a slight increase in blastoid cells
(identified by enlargement, hyperchromasia, and pleomorphism) in Mttp-IKO mice (A, n = 10–11/group, p = 0.04) but no difference in
hematolymphoid cells (B, n = 10–11/group, p.0.05). In the spleen, there were increases in blastoid cells (C, n = 10–11/group, p = 0.0006) and
megakaryocytes (D, n = 10–11/group, p = 0.001) in Mttp-IKO mice but no differences in tingible body macrophages (E, n =N= 10–11/group, p.0.05).
doi:10.1371/journal.pone.0101828.g007
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was associated with a host milieu that was sufficiently different that
blocking intestinal chylomicrons had a profoundly different effect.
This study has a number of limitations. All mechanistic studies
were performed at 24 hours, and we therefore do not know how or
if any of the parameters altered in aged septic Mttp-IKO mice
changed over time compared to septic WT mice. This especially
limits interpretation of the cytokine data, in light of the fact that
cytokine levels are highly dynamic following sepsis [78,79].
Further, although we compared septic aged matched Mttp-IKO
and WT mice, it is important to recognize that intestinal Mttp
deletion was imposed for only 3–4 weeks in these mice. The effects
of sustained Mttp deletion in aging mice was not examined and it is
unknown whether these mice would tolerate virtually lifelong
attenuation of lipid absorption. Accordingly, while we previously
compared young unmanipulated Mttp-IKO and WT mice, it is
possible that aging results in local and systemic phenotypic
differences between these animals not seen in young mice. As such,
some of the differences noted in aged septic Mttp-IKO and WT
mice might have already been different prior to the onset of
pneumonia. It is also important to mention that the mice used
were generated from two inbred strains. There is significant
controversy as to whether inbred animals are appropriate
surrogates for humans which obviously have more genetic
diversity [14,80,81], and our results must be interpreted in light
of the fact that they were derived from two inbred strains. In
addition, excision and homogenization of the entire lung would
likely have provided a more accurate assessment of pulmonary
endpoints examined. Finally, we acknowledge that the associations
between increased mortality and the physiologic parameters
measured do not imply causation, and additional studies are
needed to determine the significance of differences identified
between septic aged matched Mttp-IKO and WT mice.
Despite these limitations, this study highlights the importance of
age in the pathophysiology of sepsis. Further, it demonstrates that
blocking intestinal chylomicron secretion can have widely varying
results in sepsis, which must be taken into account when
considering the role of mesenteric lymph in sepsis. Further
research is needed to identify the mechanisms through which
blocking intestinal chylomicron assembly alters outcomes in sepsis.
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Figure 8. Effect of impaired intestinal lipid transport on serum lipoproteins. Triglyceride (A) and cholesterol (B) in serum were measured
before and 24 hours after induction of pneumonia in the same mice. Sepsis decreased both triglyceride and cholesterol after induction of pneumonia
in WT mice (C, D, n = 16–18/group, p,0.0001 for both). Inhibiting chylomicron assembly also resulted in lower triglyceride and cholesterol at baseline
(n = 17–18/group, p,0.0001 for both). In contrast, sepsis did not alter triglyceride levels in Mttp-IKO mice (n = 11–17/group, p.0.05). Additionally,
sepsis increased cholesterol levels in Mttp-IKOmice after induction of pneumonia (n = 11–17/group, p,0.0001). Sepsis virtually eliminated triglyceride
from large, VLDL and LDL size lipoproteins in WT mice (note fractions 10 and 25, respectively). By contrast, Mttp-IKO mice exhibited virtually no
triglyceride in lipoprotein particles, as expected. Sepsis resulted in an increase in HDL cholesterol content in Mttp-IKO mice (fractions 38–40). Serum
bile acids (E) were similar between WT and Mttp-IKO mice (n = 7–8/group, p.0.05).
doi:10.1371/journal.pone.0101828.g008
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